Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Coleman

Showing results (201-210 of 510) with videos related to

Pageof 51
Sort By:
Thrombosis Research|March 22, 2015
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysisDiana M Sobieraj, Craig I Coleman, Vinay Pasupuleti, et al.
Thrombosis Research|February 7, 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable stateCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Clinical Therapeutics|May 19, 2020
Communication of Medication Nonmedical Switching Policies and Procedures by Insurance Companies: Results of an E-SurveyTabassum Salam, Amy Duhig, Aarti A Patel, et al.
JAMA|January 15, 2004
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trialBrian F McBride, Angeliki K Karapanos, Agnes Krudysz, et al.
Journal of the American Heart Association|January 16, 2020
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk FactorsBenjamin Miao, Adrian V Hernandez, Mark J Alberts, et al.
The American Journal of Medicine|December 25, 2018
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTECraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
The Annals of Pharmacotherapy|June 30, 2005
Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysisEffie L Gillespie, Craig I Coleman, Stephen Sander, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 25, 2013
Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patientsSanjeev P Bhavnani, Craig I Coleman, Danette Guertin, et al.
Heart Rhythm|March 26, 2008
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunctionCraig I Coleman, Jeffrey Kluger, Sanjeev Bhavnani, et al.
JAACAP Open|November 18, 2024
Relative Age Effects on Attention-Deficit/Hyperactivity Disorder Symptoms and Educational Achievement: A Longitudinal UK Cohort StudyQigang Deng, Jonathan R I Coleman, Ethan Mottershead, et al.
Pageof 51

Showing results (201-210 of 510) with videos related to

Sort By:
Pageof 51
Thrombosis Research|March 22, 2015
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysisDiana M Sobieraj, Craig I Coleman, Vinay Pasupuleti, et al.
Thrombosis Research|February 7, 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable stateCraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Clinical Therapeutics|May 19, 2020
Communication of Medication Nonmedical Switching Policies and Procedures by Insurance Companies: Results of an E-SurveyTabassum Salam, Amy Duhig, Aarti A Patel, et al.
JAMA|January 15, 2004
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trialBrian F McBride, Angeliki K Karapanos, Agnes Krudysz, et al.
Journal of the American Heart Association|January 16, 2020
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk FactorsBenjamin Miao, Adrian V Hernandez, Mark J Alberts, et al.
The American Journal of Medicine|December 25, 2018
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTECraig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
The Annals of Pharmacotherapy|June 30, 2005
Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysisEffie L Gillespie, Craig I Coleman, Stephen Sander, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 25, 2013
Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patientsSanjeev P Bhavnani, Craig I Coleman, Danette Guertin, et al.
Heart Rhythm|March 26, 2008
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunctionCraig I Coleman, Jeffrey Kluger, Sanjeev Bhavnani, et al.
JAACAP Open|November 18, 2024
Relative Age Effects on Attention-Deficit/Hyperactivity Disorder Symptoms and Educational Achievement: A Longitudinal UK Cohort StudyQigang Deng, Jonathan R I Coleman, Ethan Mottershead, et al.
Pageof 51